Hantz Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Buy |
214
+112
| +110% | +$8.9K | ﹤0.01% | 1325 |
|
|
2025
Q1 | $7K | Buy |
102
+24
| +31% | +$1.65K | ﹤0.01% | 1049 |
|
|
2024
Q4 | $6K | Sell |
78
-1,777
| -96% | -$137K | ﹤0.01% | 867 |
|
|
2024
Q3 | $122K | Sell |
1,855
-457
| -20% | -$30.1K | ﹤0.01% | 596 |
|
|
2024
Q2 | $214K | Sell |
2,312
-40
| -2% | -$3.7K | ﹤0.01% | 560 |
|
|
2024
Q1 | $225K | Sell |
2,352
-71
| -3% | -$6.79K | ﹤0.01% | 557 |
|
|
2023
Q4 | $185K | Sell |
2,423
-5,909
| -71% | -$451K | ﹤0.01% | 562 |
|
|
2023
Q3 | $577K | Buy |
8,332
+5,704
| +217% | +$395K | 0.01% | 469 |
|
|
2023
Q2 | $248K | Buy |
2,628
+151
| +6% | +$14.3K | 0.01% | 525 |
|
|
2023
Q1 | $205K | Buy |
2,477
+570
| +30% | +$47.2K | 0.01% | 542 |
|
|
2022
Q4 | $142K | Buy |
1,907
+95
| +5% | +$7.07K | ﹤0.01% | 555 |
|
|
2022
Q3 | $150K | Hold |
1,812
| – | – | 0.01% | 534 |
|
|
2022
Q2 | $172K | Sell |
1,812
-261
| -13% | -$24.8K | 0.01% | 522 |
|
|
2022
Q1 | $244K | Buy |
2,073
+279
| +16% | +$32.8K | 0.01% | 509 |
|
|
2021
Q4 | $232K | Hold |
1,794
| – | – | 0.01% | 498 |
|
|
2021
Q3 | $203K | Hold |
1,794
| – | – | 0.01% | 490 |
|
|
2021
Q2 | $186K | Hold |
1,794
| – | – | 0.01% | 460 |
|
|
2021
Q1 | $150K | Hold |
1,794
| – | – | 0.01% | 460 |
|
|
2020
Q4 | $164K | Buy |
+1,794
| New | +$164K | 0.01% | 417 |
|